SODIUM 9-DEHYDRO-17-HYDRO-ANDROGRAPHOLIDE-19-YL SULFATE
UNII Z5RVW4Z10Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Sodium 9-dehydro-17-hydro-andrographolide-19-yl Sulfate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z5RVW4Z10Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1443513-92-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Z5RVW4Z10Q
CAS Registry Number
1443513-92-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SODIUM 9-DEHYDRO-17-HYDRO-ANDROGRAPHOLIDE-19-YL SULFATE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C20H29O8S.Na
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
PVFDPMYXCZLHKY-MLLWLMKGSA-M
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
72191954
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O=C\1OC[C@H](/C1=C\CC=2[C@@]3(CC[C@@H](O)[C@]([C@@]3([H])CCC2C)(COS([O-])(=O)=O)C)C)O.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sodium 9-dehydro-17-hydro-andrographolide-19-yl Sulfate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ANDROGRAPHOLIDE SULFONATE SODIUM [WHO-DD]
DHAS
SODIUM 9-DEHYDRO-17-HYDRO-ANDROGRAPHOLIDE-19-YL SULFATE
XIYANPING COMPONENT SODIUM 9-DEHYDRO-17-HYDRO-ANDROGRAPHOLIDE-19-YL SULFATE

Systematic Nomenclature

2(3H)-FURANONE, DIHYDRO-4-HYDROXY-3-(2-((4AS,5R,6R,8AR)-3,4,4A,5,6,7,8,8A-OCTAHYDRO-6-HYDROXY-2,5,8A-TRIMETHYL-5-((SULFOOXY)METHYL)-1-NAPHTHALENYL)ETHYLIDENE)-, SODIUM SALT (1:1), (3E,4S)-

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound